Semmax Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$129K Buy
1,596
+395
+33% +$31.4K 0.03% 144
2025
Q1
$91.2K Buy
1,201
+12
+1% +$1.12K 0.02% 146
2024
Q4
$100K Buy
1,189
+9
+0.8% +$928 0.03% 141
2024
Q3
$116K Sell
1,180
-10
-0.8% -$1.19K 0.03% 130
2024
Q2
$136K Buy
1,190
+1,172
+6,511% +$151K 0.04% 130
2024
Q1
$2.37K Sell
18
-55
-75% -$6.78K ﹤0.01% 292
2023
Q4
$9.19K Buy
73
+36
+97% +$3.74K ﹤0.01% 216
2023
Q3
$3.81K Buy
+37
New +$3.99K ﹤0.01% 245
2020
Q4
Sell
-64
Closed -$5K 265
2020
Q3
$5K Hold
64
﹤0.01% 173
2020
Q2
$5K Hold
64
﹤0.01% 190
2020
Q1
$5K Hold
64
﹤0.01% 185
2019
Q4
$6K Sell
64
-255
-80% -$20.9K ﹤0.01% 203
2019
Q3
$26K Buy
319
+228
+251% +$18.3K 0.02% 135
2019
Q2
$7K Sell
91
-178
-66% -$13.6K ﹤0.01% 206
2019
Q1
$21K Buy
269
+187
+228% +$14K 0.01% 263
2018
Q4
$6K Buy
+82
New +$5.79K ﹤0.01% 347

Other funds holding MRK

Semmax Financial Advisors's MRK Position: Q2 2025 in Review

Semmax Financial Advisors increased its Merck (MRK) stake by 33% in Q2 2025, buying an estimated $31.4K and bringing the position to 1,596 shares worth $129K. The position accounts for 0.03% of the portfolio, ranked #144.

Semmax Financial Advisors first reported a position in MRK in Q4 2018 and has held it in 16 quarters since. The position peaked at $136K in Q2 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Semmax Financial Advisors held 1,596 shares of Merck worth $129K as of Q2 2025.
  • Semmax Financial Advisors bought 395 Merck shares in Q2 2025, an estimated $31.4K.
  • Merck made up 0.03% of Semmax Financial Advisors's portfolio in Q2 2025, its #144 holding.
  • Semmax Financial Advisors first reported a position in Merck in Q4 2018 and has held it in 16 quarters since.
  • Semmax Financial Advisors's Merck position peaked at $136K in Q2 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.